U.S. Food & Drug Administration Completes Food Additive Review of Arcadia Biosciences’ SONOVA® 400 GLA Safflower Oil for U...
April 19 2017 - 8:00AM
Business Wire
-- Rich source of gamma-linolenic acid
provides multiple health benefits for pets --
Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural
technology company, announced today that the U.S. Food and Drug
Administration (FDA) has completed its review of Arcadia’s food
additive petition for the use of the company’s high gamma-linolenic
acid (GLA) safflower oil in dog diets. The FDA concluded that the
data provided by Arcadia supports the safety and functionality of
GLA safflower oil as a source of omega-6 fatty acids in dry food
for adult dogs. The petition will be approved when the final rule
is published in the Federal Register.
Arcadia’s SONOVA GLA safflower oil provides a rich source of
omega-6 fatty acids GLA and linoleic acid (LA) and has been used in
human nutritional supplements since its approval by the FDA in
2009. Clinical studies have shown that GLA offers similar benefits
for pets, including weight management, control of pruritus and
other dermatological conditions, mobility-related arthritic
conditions and immune system disorders. Arcadia’s SONOVA GLA
safflower oil contains a minimum of 40 percent GLA, which is
approximately two to four times greater than most other commercial
sources, making it the most concentrated and cost-effective plant
oil source of GLA available.
“The FDA’s approval of Arcadia’s petition opens up an expanded
opportunity for SONOVA GLA safflower oil as a source of omega-6
fatty acids in pet nutrition, a growing specialty market,” said,
Raj Ketkar, president and CEO of Arcadia Biosciences. “This
approval also demonstrates Arcadia’s strong regulatory capabilities
and commitment toward creating the greatest possible value for our
entire product portfolio.”
Arcadia is currently working with a number of pet nutrition
companies who will be testing the product in their dog food
formulations. For more information, visit:
www.sonovaglapet.com.
About Arcadia Biosciences, Inc.
Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA)
develops agricultural products that create added value for farmers
while benefitting the environment and enhancing human health.
Arcadia’s agronomic performance traits, including Nitrogen Use
Efficiency, Water Use Efficiency, Salinity Tolerance, Heat
Tolerance and Herbicide Tolerance, are all aimed at making
agricultural production more economically efficient and
environmentally sound. Arcadia’s nutrition traits and products are
aimed at creating healthier ingredients and whole foods with lower
production costs. For more information, visit
www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements relating to the company’s GLA safflower
oil products and the regulatory process for such products.
Forward-looking statements are subject to risks and uncertainties
that could cause actual results to differ materially, and reported
results should not be considered as an indication of future
performance. These risks and uncertainties include, but are not
limited to: the company’s and its partners’ and affiliates’ ability
to identify and isolate desired traits; the company’s and its
partners’ ability to develop commercial products incorporating GLA
safflower oil, and complete the regulatory review process for such
products; the company’s compliance with laws and regulations that
impact the company’s business, and changes to such laws and
regulations; the company’s future capital requirements and ability
to satisfy its capital needs; and the other risks set forth in the
company’s filings with the Securities and Exchange Commission from
time to time, including the risks set forth in the company’s Annual
Report on Form 10-K for the year ended December 31, 2016. These
forward-looking statements speak only as of the date hereof, and
Arcadia Biosciences, Inc. disclaims any obligation to update these
forward-looking statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170419005475/en/
Arcadia Biosciences, Inc.Jeff Bergau,
+1-312-217-0419jeff.bergau@arcadiabio.com
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Apr 2023 to Apr 2024